Vanguard disaggregates holdings; Accendra Health (ACH) listed as 0 shares in amendment

Rhea-AI Filing Summary

Accendra Health Inc amendment to a Schedule 13G/A states that The Vanguard Group reports 0 shares beneficially owned of Accendra Health Inc common stock as of the filing. The amendment notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries report beneficial ownership separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/26/2026.

Insights

Governance & Compliance Analyst

Vanguard disaggregated holdings after internal realignment; reports zero beneficial ownership here.

The filing documents an internal reorganization at The Vanguard Group and states that certain subsidiaries now report holdings separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The amendment lists 0 shares beneficially owned and 0% of the class.

Implications are procedural: this is a reporting allocation change rather than a disclosed market trade. Subsequent filings by Vanguard subsidiaries may show holdings if applicable; timing and amounts for any such filings are not included in the provided excerpt.

Institutional Ownership Specialist

This amendment reflects recordkeeping and SEC reporting alignment, not an investment decision.

The text explains that post-realignment, Vanguard no longer is deemed to beneficially own securities held by certain subsidiaries, which will report separately. The filing explicitly states no sole or shared voting or dispositive power over Accendra Health common stock.

Cash-flow treatment or transfers are not described in the excerpt; any ownership or voting signals would appear in separate schedules filed by the named subsidiaries if they hold shares.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 19)

Accendra Health Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

(CUSIP Number)

03/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Accendra Health Inc
(b)	Address of issuer's principal executive offices: 10900 Nuckols Rd, Ste 400, Glen Allen, VA, 23060
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd.,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	03/26/2026

FAQ

What does the Schedule 13G/A amendment say about Accendra Health (ACH) ownership?

It states directly that The Vanguard Group beneficially owns 0 shares (0%) of Accendra Health common stock. The amendment attributes this to an internal Vanguard realignment and separate reporting by subsidiaries effective January 12, 2026.

Why does Vanguard report separate holdings after January 12, 2026?

Because Vanguard underwent an internal realignment; certain subsidiaries now report holdings separately under SEC Release No. 34-39538. The amendment explains subsidiaries will report disaggregated beneficial ownership and Vanguard is no longer deemed to own those subsidiary holdings.

Who signed the amendment and when was it filed for Accendra Health (ACH)?

The amendment is signed by Ashley Grim, Head of Global Fund Administration and is dated 03/26/2026. The cover indicates the amendment number as Amendment No. 19 filed on 03/13/2026 in the provided excerpt.

Does the filing disclose any voting or dispositive power by Vanguard over ACH shares?

No; the filing lists 0 for sole and shared voting power and 0 for sole and shared dispositive power. The table rows for voting and disposition powers are all reported as 0 in the amendment.

Will this amendment change Accendra Health’s share register or outstanding share count?

No; the amendment only reports beneficial ownership information for Vanguard and does not change the company’s share register or outstanding share count. It documents reporting allocation following Vanguard’s internal realignment and contains no corporate-capital actions.